Premium
THIRTY YEARS EXPERIENCE WITH HEART VALVE SURGERY: ISOLATED MITRAL VALVE REPLACEMENT
Author(s) -
Bessell Justin R.,
Gower Georgina,
Craddock David R.,
Stubberfield John,
Maddern Guy J.
Publication year - 1996
Publication title -
australian and new zealand journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.111
H-Index - 51
eISSN - 1445-2197
pISSN - 0004-8682
DOI - 10.1111/j.1445-2197.1996.tb00754.x
Subject(s) - medicine , atrial fibrillation , mitral valve replacement , stenosis , surgery , mitral valve , complication , prosthesis , retrospective cohort study , cardiac surgery , cardiology
Background : Thirty years have elapsed since the commencement of open‐heart surgery in South Australia. A retrospective study was performed to evaluate mortality and complication rates and to identify factors associated with poor outcomes in all patients who underwent prosthetic mitral valve replacement during this period. Methods : Questionnaires and personal contact have been used to generate a combined database of pre‐operative and postoperative information and long‐term follow‐up on 938 patients who underwent isolated prosthetic mitral valve replacement at the Cardio‐Thoracic Surgical Unit of the Royal Adelaide Hospital between 1963 and 1993. Results : Complete survival follow‐up data were obtained for 92% (865) of the patients. The Starr‐Edwards valve was used in 95% (891) of the patients, a Bjork‐Shiley prosthesis in 2.5% (23) of the patients, and only 24 (2.5%) other valves were inserted. The hospital mortality rate for the 30‐year period was 4.7%. The mean age of the patients who underwent surgery was greater in each of the three successive decades. A long‐term survival advantage was observed for patients with mitral stenosis, however, survival was significantly shorter for patients with higher New York Heart Association (NYHA) functional classifications and for patients in pre‐operative atrial fibrillation. Pre‐operative dyspnoea was significantly improved following mitral valve replacement. The rates of postoperative haemorrhagic and embolic complications were low by comparison with other published series. Conclusion : Mitral valve recipients do not regain a normalized life expectancy, but risk factors that determine long‐term survival can be identified pre‐operatively to aid appropriate patient selection.